Probiotics in paediatric disorders: Gut flora, potential agents and the road ahead

International Journal of Pharmaceutical Medicine

Volumn 20, Issue 1, 2006, Pages 37-48

  Kaur, Indu Pal ^a   Chopra, Anurag ^a   Chopra, Kanwaljit ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIOCIN; PROBIOTIC AGENT;

ALLERGY; ANTIBACTERIAL ACTIVITY; ASTHMA; ATOPIC DERMATITIS; BACTERIAL STRAIN; BIFIDOBACTERIUM; CHILDHOOD DISEASE; CLINICAL TRIAL; CLOSTRIDIUM; DRUG SAFETY; DRUG TOLERABILITY; ESCHERICHIA COLI; GENE TRANSFER; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOLOGY; INFANTILE DIARRHEA; INFECTION; INFECTIOUS DIARRHEA; INTESTINE LYMPHATIC TISSUE; LACTOBACILLUS CASEI; LACTOSE INTOLERANCE; NONHUMAN; PREMATURE LABOR; PRIORITY JOURNAL; REVIEW; ROTAVIRUS; SKIN ALLERGY; STREPTOCOCCUS; URINARY TRACT INFECTION; VIRAL GASTROENTERITIS;

EID: 33745485293     PISSN: 13649027     EISSN: 13649027     Source Type: Journal    
DOI: 10.2165/00124363-200620010-00004     Document Type: Review

References (132)

1. Reid G, Anand S, Bingham MO, et al. Probiotics for the developing world. J Clin Gastroenterol 2005; 39: 485-8
2. Montrose DC, Floch MH. Probiotics used in human studies. J Clin Gastroenterol 2005; 39: 469-84
3. Heselmans M, Reid G, Akkermans LM, et al. Gut flora in health and disease: potential role of probiotics. Curr Issues Intest Microbiol 2005; 6: 1-7
4. Fioramonti J, Theodorou V, Bueno L. Probiotics: what are they? What are their effects on gut physiology? Best Pract Res Clin Gastroenterol 2003; 17: 711-24
5. Salminen S, Bouley C, Boutron-Ruault MC, et al. Functional food science and gastrointestinal physiology and function. Br J Nutr 1998; 80 Suppl. 1: S147-71
6. Brandtzaeg P. Recent development in infant nutrition. Dordrecht: Huwer Academic Publishers, 1996
7. Kalliomaki M, Isolauri E. Pandemic of atopic diseases: a lack of microbial exposure in early infancy? Curr Drug Targets Infect Disord 2002; 2: 193-9
8. Hanson LA, Yolken RH. Probiotics, other nutritional factors, and intestinal microflora. Philadelphia (PA): Lippincott-Raven Press, 1999
9. Edwards CA, Parrett AM. Intestinal flora during the first months of life: new perspective. Br J Nutr 2002; 88: S11-8
10. Balmer SE, Wharfon BA. Diet and fecal flora of new born: breast milk and infant formula. Arch Dis Child 1989; 64: 1678-84
11. Fuller F. Factors affecting the composition of the intestinal microflora of the human infant. In: Heird WC, editor. Nutritional needs of the 6-12 month infant. New York: Raven Press, 1991: 121-30
12. Rullen CL, Willis AT. Resistance of breast-fed infant to gastroenteritis. BMJ 1971; 3: 338-43
13. Bullen JJ, Rodgers HJ, Leigh L. Iron binding proteins in milk and resistance to E. coli infections in infants. BMJ 1972; 1: 69-75
14. Calvo EB, Galindo AC, Aspres NB. Iron status in exclusively breast-fed infants. Pediatrics 1992; 90: 375-9
15. Siimes MA, Vuori E, Kuitenen P. Breast milk iron: a decline in concentration during the course of lactation. Acta Pediatr Scand 1979; 68: 29-31
16. Roberts AK, Chierrici R, Sawatzki G, et al. Supplementation of an adapted formula with bovine lactoferrin 1: effect on the infants faecal flora. Acta Pediatr Scand 1992; 81: 119-24
17. Kunz C, Rudolff S. Biological functions of oligosaccharides in human milk. Acta Pediatr Scand 1993; 82: 902-12
18. Balmer SE, Harvey CS, Wharton BA. Diet and faecal flora in the newborn: nucleotides. Arch Dis Child 1994; 90 Suppl. F: F137-40
19. Rueda R, Sabatel JL, Maldonado J, et al. Addition of gangliosides to an adapted milk formula modifies levels of faecal microflora in patern newborn infants. J Pediatr 1998; 133: 90-4
20. Fuller R. Probiotics in man and animals. J Appl Bacteriol 1989; 66: 365-78
21. Costalos C, Skouteri V, Gounaris A, et al. Enteral feeding of premature infants with Saccharomyces boulardii. Early Hum Dev 2003; 74: 89-96
22. Rolfe RD. The role of probiotic cultures in the control of gastrointestinal health. J Nutr 2000; 130: 396S-402S
23. Salminen SJ, Gueimonde M, Isolauri E. Probiotics that modify disease risk. J Nutr 2005; 135: 1294-8
24. Sullivan A, Nord CE. Probiotics and gastrointestinal diseases. J Intern Med 2005; 257: 78-92
25. Stanton C, Ross RP, Fitzgerald GF, et al. Fermented functional foods based on probiotics and their biogenic metabolites. Curr Opin Biotechnol 2005; 16: 198-203
26. Kumar SG, Singh SK, Goyal P, et al. Beneficial effects of probiotics and prebiotics on human health. Pharmazie 2005, 171
27. Avonts L, De Vuyst L. Antimicrobial potential of probiotic lactic acid bacteria. Meded Rijksuniv Gent Fak Landbouwkd Toegep Biol Wet 2001; 66: 543-50
28. Aroutcheva A, Gariti D, Simon M, et al. Defense factors of vaginal Lactobacilli. Am J Obstet Gynecol 2001; 185: 375-9
29. Boris S, Barbes C. Role played by Lactobacilli in controlling the population of vaginal pathogens. Microbes Infect 2000; 2: 543-6
30. Reid G, Heinemann C, Velraeds M, et al. Biosurfactants produced by Lactobacillus. Methods Enzymol 1999; 310: 426-33
31. Silva M, Jacobus NV, Deneke C, et al. Antimicrobial substance from a human Lactobacillus strain. Antimicrob Agents Chemother 1987; 31: 1231-3
32. Meurman JH, Antila H, Korhonen A, et al. Effect of Lactobacillus rhamnosus strain GG (ATCC 51303) on the growth of Streptococcus dobrinus in vitro. Eur J Oral Sci 1995; 103: 253-8
33. Vandenbergh PA. Lactic acid bacteria, their metabolic products and interference with microbial growth. FEMS Microbiol Rev 1993; 12: 221-38
34. Collado MC, Hernandez M, Sanz Y. Production of bacteriocin-like inhibitory compounds by human fecal Bifidobacterium strains. J Food Prot 2005; 68: 1034-40
35. Qin HL, Shen TY, Gao ZG, et al. Effect of Lactobacillus on the gut microflora and barrier function of the rats with abdominal infection. World J Gastroenterol 2005; 11: 2591-6
36. Absolom DR, Lamberti FV, Policova Z, et al. van Oss CJ, Neumann AW. Surface thermodynamics of bacterial adhesion. Appl Environ Microbiol 1983; 46: 90-7
37. Lee YK, Puong KY, Ouwehand AC, et al. Displacement of bacterial pathogens from mucus and Caco-2 cell surface by lactobacilli. J Med Microbiol 2003; 52: 925-30
38. Kleeman EG, Klaenhammer TR. Adherence of Lactobacillus species to human fetal intestinal cells. J Dairy Sci 1982; 65: 2063-9
39. Conway PL, Goldin BR, Gorbach SL. Survival of lactic acid bacteria in the human stomach and adhesion to intestinal cells. J Dairy Sci 1987; 70: 1-12
40. Goldin BR, Gorbach SL, Saxelin M, et al. Survival of Lactobacillis species (strain GG) in human gastrointestinal tract. Dig Dis Sci 1992; 37: 121-8
41. Osset J, Bartolome RM, Garcia E, et al. Assessment of the capacity of Lactobacillus to inhibit the growth of uropathogens and block their adhesion to vaginal epithelial cells. J Infect Dis 2001; 183: 485-91
42. Rigothier MC, Maccario J, Gayral P. Inhibitory activity of Sacchromyces yeasts on the adhesion of Entamoeba histolytica trophozoites to human erythrocytes in vitro. Parasitol Res 1994; 80: 10-5
43. Gill HS. Probiotics to enhance anti-infective defences in the gastrointestinal tract. Best Pract Res Clin Gastroenterol 2003; 17: 755-73
44. Saxelin M, Tynkkynen S, Mattila-Sandholm T, et al. Probiotic and other functional microbes: from markets to mechanisms. Curr Opin Biotechnol 2005; 16: 204-11
45. Kaila M, Isolauri E, Soppi E, et al. Enhancement of the circulating antibody secreting cell response in human diarrhoea by a human Lactobacilli strain. Pediatr Res 1992; 32: 141-4
46. Kaila M, Isolauri E, Saxelin M, et al. Viable versus inactivated Lactobacillus strain GG in acute rotavirus diarrhoea. Arch Dis Child 1995; 72: 51-3
47. Mack DR, Michail S, Wei S, et al. Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression. Am J Physiol 1999; 276: G941-50
48. Buts JP, Bernasconi P, Van Craynest MP, et al. Response of human and rat small intestine mucosa to oral administration of Sacchromyces boulardii. Pediatr Res 1986; 20: 192-6
49. Buts JP, Bernasconi P, Vaerman JP, et al. Stimulation of secretory components of immunoglobulins in small intestine of rats treated with Sacchromyces boulardii. Dig Dis Sci 1990; 35: 251-6
50. Patholakis G, Kelly CP, Joshi MA, et al. Saccharomyces boulardii inhibits Clostridium difficle toxin A binding and enterotoxicity in rat ileum. Gastroenterology 1993; 104: 1108-15
51. Ulisse S, Gionchetti D'Alos, Russo FP, et al. Expression of cytokines, inducible nitric oxide synthase and matrix metalloproteinases in pouchitis: effect of probiotic treatment. Am J Gastroenterol 2001; 96: 2691-9
52. Wullt B, Bergsten G, Connel H, et al. P-fimbriae trigger mucosal responses to E. coli in the human urinary tract. Cell Microbiol 2001; 3: 255-64
53. Rycroft CE, Jones MR, Gibson S, et al. Ability of Lactobacillus GR-1 and RC-14 to stimulate host defences and reduce gut translocation and infectivity of Salmonella typhimurium. Nutraceutical Food 2002; 7: 168
54. Wilson KH, Perini F. Role of competition for nutrients in suppression of Clostridium difficile by the colonic microflora. Infect Immunol 1988; 56: 2610-4
55. Tuohy KM, Probert HM, Smejkal CW, et al. Using probiotics and prebiotics to improve gut health. Drug Discov Today 2003; 8: 692-700
56. Meier R, Burri E, Steuerwald M. The role of nutrition in diarrhoea syndromes. Curr Opin Clin Nutr Metab Care 2003; 6: 563-7
57. Szajewska H, Mrukowicz JZ. Use of probiotics in children with acute diarrhoea. Paediatr Drugs 2005; 7: 111-22
58. Madden JA, Plummer SF, Tang J, et al. Effect of probiotics on preventing disruption of the intestinal microflora following antibiotic therapy: a double-blind, placebo-controlled pilot study. Int Immunopharmacol 2005; 5: 1091-7
59. Vanderhoof JA, Whitney DB, Autonson DL, et al. Lactobacillus GG in the prevention of antibiotic-associated diarrhoea in children. J Pediatr 1999; 135: 564-8
60. Arvola T, Laibo K, Torkkeli S, et al. Prophylactic Lactobacillus GG reduces antibiotic-associated diarrhoea in children with respiratory infections: a randomized study. Pediatrics 1999; 104 (5): e64
61. Biller JA, Katz AJ, Flores AF, et al. Treatment of recurrent Clostridium difficile colitis with Lactobacillius GG. J Pediatr Gastroenterol Nutr 1995; 21: 224-6
62. Synder JD, Merson MH. The magnitude of the global problem of acute diarrhoeal disease: a review of surveillance data. Bull World Health Organ 1982; 60: 605-13
63. Isolauri E, Kaila M, Mykkanen H, et al. Oral bacteriotherapy for viral gastroenteritis. Dig Dis Sci 1994; 39: 2595-600
64. Luyer MD, Buurman WA, Hadfoune M, et al. Strain-specific effects of probiotics on gut barrier integrity following hemorrhagic shock. Infect Immun 2005; 73: 3686-92
65. Teitelbaum JE. Probiotics and the treatment of infectious diarrhoea. Pediatr Infect Dis J 2005; 24: 267-8
66. Isolauri E, Juntunen M, Rautanen T. Lactic acid bacteria in the treatment of acute rotavirus gastroenteritis. J Pediatr Gastroenterol Nutr 1995; 20: 333-9
67. Bengmark S. Immunonutrition: role of biosurfactants, fibre and probiotic bacteria. Nutrition 1998; 14: 585-94
68. Guarino A, Canani RB, Spagnuolo MI, et al. Oral bacterial therapy reduces the duration of symptoms and of viral excretion in children with mild diarrhoea. J Pediatr Gastroenterol Nutr 1997; 25: 516-9
69. Isolauri E, Kaila M, Arvola T, et al. Diet during rotavirus enteritis affects jejunal permeability to macromolecules in suckling rats. Pediatr Res 1993; 33: 548-53
70. Majamaa H, Isolauri E, Saxelin M, et al. Lactic acid bacteria in the treatment of acute rotavirus gastroenteritis. J Pediatr Gastroenterol Nutr 1995; 20: 333-8
71. Saavedra JM, Baumann NA, Oung I. Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhoea and shedding of rotavirus. Lancet 1994; 334: 1046-9
72. Isolauri E, Kirjavainen PV, Salminen S. Prebiotics: a role in the treatment of intestinal infection and inflammation? Gut 2002 May; 50 Suppl. 3: 54-9
73. Jonathan E, Markowitz MD, Bengmark S. Probiotics in health and disease in the pediatric patient. Pediatr Clin North Am 2002; 49: 127-41
74. Szajewska H, Kotowska M, Mrukowicz JZ, et al. Efficacy of Lactobacillus GG in prevention of nosocomial diarrhoea in infants. J Pediatr 2001; 138: 361-5
75. Allen SJ, Okoko B, Martinez E, et al. Probiotics for treating infectious diarrhoea. Cochrane Database Syst Rev 2004; 2: CD003048
76. Vanderhoof JA, Young RJ. Current and potential uses of probiotics. Ann Allergy Asthma Immunol 2004; 93: S33-7
77. Kurugol Z, Koturoglu G, Kurugol Z, et al. Effects of Saccharomyces boulardii in children with acute diarrhoea. Acta Paediatr 2005; 94: 44-7
78. Heyman M, Menard S. Probiotic microorganisms: how they affect intestinal pathophysiology. Cell Mol Life Sci 2002; 59: 1151-65
79. Reid G, Jass J, Sebulsky MT, et al. Potential uses of probiotics in clinical practice. Clin Microbiol Rev 2003; 16: 658-72
80. Roggero P, Volge C, Ceccatelli MP, et al. Crystalline lactulose and oral preparations of microorganisms for the treatment of chronic specific diarrhoea in children: a controlled clinical study [in Italian]. Minerva Pediatr 1990; 42: 147-50
81. Gonzalez SN, Cardozo R, Apella MC, et al. Biotherapeutic role of fermented milk. Biotherapy 1994; 8: 129-34
82. Gaon D, Garcia H, Winter L, et al. Effect of Lactobacillus strains and Saccharomyces boulardii on persistent diarrhea in children. Medicina (B Aires) 2003; 63: 293-8
83. Weizman Z, Asli G, Alsheikh A. Effect of a probiotic infant formula on infections in child care centers: comparison of two probiotic agents. Pediatrics 2005; 115: 5-9
84. Harms HK, Bertele-Harms RM, Bruer-Kleis D. Enzyme-bstitution therapy with the yeast Saccharmyces cerevisiae in congenital sucrose-isomaltase deficiency. N Engl J Med 1987; 316: 1306-9
85. Shah N. Effectiveness of dairy products in alleviation of lactose intolerance. Food Australia 1993; 45: 268-71
86. Yesovitch R, Cohen A, Szilagyi A. Failure to improve parameters of lactose maldigestion using the multiprobiotic product VSL3 in lactose maldigesters: a pilot study. Can J Gastroenterol 2004; 18: 83-6
87. Savino A, Levitt MD. Milk intolerance and microbe containing dairy foods. J Dairy Sci 1987; 70: 397-401
88. Sherman PM. Probiotics and lactose maldigestion. Can J Gastroenterol 2004; 18: 81-2
89. Kim HS, Gilliland S. Lactobacillus acidophilus as a dietary adjunct for milk to aid lactose digestion in humans. J Dairy Sci 1987; 66: 956-9
90. Savaiano DA, Abou El Anouar A, Smith DE, et al. Lactose malabsorption from yoghurt, pasteurised yoghurt, sweet acidophilus milk, and cultured milk in lactose deficient individuals. Am J Clin Nutr 1984; 40: 1219-23
91. Kolars JC, Lewitt MD, Aouji M, et al. Yoghurt an autodigesting source of lactose. N Engl J Med 1984; 310: 1-3
92. Marteau P, Flourie B, Pochart P, et al. Role of microbial Lactose (EC 3.2.123) activity from yoghurt on the intestinal absorption of lactose: an in vivo study in lactose deficient humans. Br J Nutr 1990; 64: 71-9
93. Marteau P, Vesa T, Rambaud JC. Lactose maldigestion. In: Fuller R, editor. Probiotics 2: applications and practical aspects. London: Chapman & Hall, 1997: 65-88
94. Vesa TH, Marteau P, Zidi S, et al. Digestion and tolerance of lactose from yoghurt and different semi-solid fermented dairy products containing Lactobacillus acidophilus and Bifidobacteria in lactose maldigesters: Is bacterial lactose important? Eur J Clin Nutr 1996; 50: 730-3
95. Gaon D, Doweck Y, Gomez Zavaglia A, et al. Lactose digestion by milk fermented with Lactobacillus acidophilus and Lactobacillus casei of human origin. Medicina (B Aires) 1995; 55: 237-42
96. Fraga M, Scavone P, Zunino P. Preventive and therapeutic administration of an indigenous Lactobacillus sp. strain against Proteus mirabilis ascending urinary tract infection in a mouse model. Antonie Van Leeuwenhoek 2005; 88: 25-34
97. Reid G, Bruce AW. Urogenital infections in women: can probiotics help? Postgrad Med J 2003; 79: 428-32
98. Reid G, Bocking A. The potential for probiotics to prevent bacterial vaginosis and preterm labor. Am J Obstet Gynecol 2003; 189: 1202-8
99. Hoesl CE, Altwein JE. The probiotic approach: an alternative treatment option in urology. Eur Urol 2005; 47: 288-96
100. Isolaurri E, Turajanmaa K. Combined skin prick and patch testing enhances identification of food allergy in infants with atopic dermatitis. J Allergy Clin Immunol 1995; 97: 9-17
101. Martinez FD, Holt PG. Atopic dermatitis and gut flora. Lancet 1999; 354: S2
102. Ogden NS, Bielory L. Probiotics: a complementary approach in the treatment and prevention of pediatric atopic disease. Curr Opin Allergy Clin Immunol 2005; 5: 179-84
103. Viljanen M, Savilahti E, Haahtela T, et al. Probiotics in the treatment of atopic eczema/dermatitis syndrome in infants: a double-blind placebo-controlled trial. Allergy 2005; 60: 494-500
104. Bongaerts GP, Severijnen RS. Preventive and curative effects of probiotics in atopic patients. Med Hypotheses 2005; 64: 1089-92
105. Kallimaki M, Salminen S, Arvilommi H, et al. Probiotics in primary prevention of atopic disease a randomized placebo-controlled trail. Lancet 2001; 357: 1076-9
106. Majamaa H, Isolaurii E. Probiotics: a novel approach in the management of food allergy. J Allergy Clin Immunol 1997; 99: 179-85
107. Kalliomaki MA, Isolauri E. Probiotics and down-regulation of the allergic response. Immunol Allergy Clin North Am 2004; 24: 739-52
108. Kailasapathy K, Chin J. Survival and therapeutic potential of probiotic organisms with reference to Lactobacillus acidophilus and Bifidobacterium spp. Immunol Cell Biol 2000; 78: 80-8
109. Gill HS. Stimulation of the immune system by lactic cultures. Int Dairy J 1998; 8: 535-44
110. Fooks LJ, Gibson GR. Probiotics as modulators of the gut flora. Br J Nutr 2002; 88: S39-49
111. Halpern GM, Vruwink KG, Vande Water J, et al. Influence of long-term yogurt consumption in young adults. Int J Immunotherapy 1991; 7: 205-10
112. Perdigon G, Alvarez S, Nader de Macias ME, et al. The oral administration of lactic acid bacteria increase the mucosal intestinal immunity in response to enteropathogens. J Food Prot 1990; 53: 404-10
113. Hatcher GE, Lambrecht RS. Augmentation of macrophage phagocytic activity by cell-free extract of selected lactic acid-producing bacteria. J Dairy Sci 1993; 76: 2482-92
114. Berufsgenossenschaft der chemischen Industrie (BMA). Engruppierung of biological agents: bacteria. Sichese biotechnology, Meskbalt B006 1997; 2: 97
115. Saxelin M, Chuang NH, Chassy B, et al. Lactobacilli and bacteremia in southern Finland: 1989-92. Clin Infect Dis 1996; 22: 564-6
116. Saxelin M, Rautelin H, Salminen S, et al. The safety of commercial products with viable Lactobacillus strains. Infect Dis Clin Prac 1996; 5: 331-5
117. Stansbridge EM, Walker V, Hall MA, et al. Effects of feeding premature infants with Lactobacillus GG on gut fermentation. Arch Dis Child 1993; 69: 488-92
118. Cunningham-Rundles S, Ahrne S, Bengmark S, et al. Probiotics and immune response. Am J Gastroenterol 2001; 95: 22-5
119. Donobue DC, Deighton M, Ahokas JT. Toxicity of lactic acid bacteria. In: Salminen S, Von W, Right A, editors. Lactic acid bacteria. New York: Marcel Dekker, 1993: 307-13
120. Steidler L, Hans W, Schotte L, et al. Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. Science 2000; 289: 1352-5
121. Pletincx M, Legein J, Vandenplas Y. Fungemia with Sacchromyces boulardii in a 1-year-old girl with protacted diarrhoea. J Pediatr Gastroenterol Nutr 1995; 21: 113-5
122. Rijnders BJ, Van Wijngaerden E, Verwaest C, et al. Sacchromyes fungemia complicating Saccharomyces boulardii treatment in a non-immumocompromised host. Intensive Care Med 2000; 26: 825
123. Geoffrey P, Davidson, Ross NB. Probiotics in pediatric gastrointestinal disorders. Curr Opin Pediatr 2000; 12: 477-81
124. Hartke A, Bouche S, Giard JC, et al. The lactic acid stress response to lactococcus lactis subsp. lactis. Curr Microbiol 1996; 33: 194-9
125. Kets EPW, Teunissen PJM, de Bont JAM. Effect of compatible solutes on survival of lactic acid bacteria subjected to drying. Appl Environ Microbiol 1996; 62: 259-61
126. Gorbach SL, Goldin BR. Lactobacillus GG [online]. Available from URL: http://www.culturelle.com/files/Culturelle_Selected_Research_Abstracts.pdf [Accessed 2005 Dec 6]
127. WHO global strategy for food safety: safer food for better health. Geneva: World Health Organization, 2002 [online]. Available from URL: http://www.who.int/foodsafety/publications/general/global_strategy/en/ [Accessed 2006 Feb 28]
128. Reid G. The importance of guidelines in the development and application of probiotics. Curr Pharm Des 2005; 11: 11-6
129. Boswell C, Zhang Z. Stabilization and targeted of probiotic micro-organisms. Biotechnol News Issue 2002; 45: 12-6
130. Calianan M. Mining the probiotic genome: advanced strategies, enhanced benefits, perceived obstacles. Curr Pharm Des 2005; 11: 25-36
131. Timmerman HM, Koning CJ, Mulder L, et al. Monostrain, multistrain and multispecies probiotics: a comparison of functionality and efficacy. Int J Food Microbiol 2004; 96: 219-33
132. FAO/WHO Evaluation of health and nutritional properties of powder milk and live lactic acid bacteria. Food and Agriculture Organisation of the United Nations and World Health Organization Expert Consultation Report. 2001 [online]. Available from URL: http://www.fao.org/es/ESN/Probio/probio.htm [Accessed 2006 Feb 28]